Apc Tumor Suppressor Gene Is the "Zonation-Keeper" of Mouse Liver

Developmental Cell

Volumn 10, Issue 6, 2006, Pages 759-770

  Benhamouche, Samira ^a,b,c,d   Decaens, Thomas ^a,b,c,d   Godard, Cécile ^a,b,c,d   Chambrey, Régine ^e   Rickman, David S ^g   Moinard, Christophe ^f   Vasseur Cognet, Mireille ^a,b,c,d   Kuo, Calvin J ^h   Kahn, Axel ^a,b,c,d   Perret, Christine ^a,b,c,d   Colnot, Sabine ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f Laboratoire de Pharmacognosie   (France)

^g Cartes d'Identité des Tumeurs Program   (France)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DEVBIO; HUMDISEASE

Indexed keywords

AMMONIA; APC PROTEIN; BETA CATENIN; GLUTAMINE; WNT PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; GENE EXPRESSION; INFECTION; LIVER; LIVER CELL; METABOLISM; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UREA CYCLE; ZONATION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADENOVIRIDAE; AMMONIA; ANIMALS; BETA CATENIN; GENE EXPRESSION REGULATION; GENES, APC; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HEPATOCYTES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NITROGEN; SIGNAL TRANSDUCTION; UREA; WNT PROTEINS;

ADENOVIRIDAE;

EID: 33744495398     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devcel.2006.03.015     Document Type: Article

References (47)

1. Andreu P., Colnot S., Godard C., Gad S., Chafey P., Niwa-Kawakita M., Laurent-Puig P., Kahn A., Robine S., Perret C., and Romagnolo B. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development 132 (2005) 1443-1451
2. Bartels H., Linnemann H., and Jungermann K. Predominant localization of phosphoenolpyruvate carboxykinase mRNA in the periportal zone of rat liver parenchyma demonstrated by in situ hybridization. FEBS Lett. 248 (1989) 188-194
3. Batlle E., Henderson J.T., Beghtel H., van den Born M.M., Sancho E., Huls G., Meeldijk J., Robertson J., van de Wetering M., Pawson T., and Clevers H. β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111 (2002) 251-263
4. Brocardo M., Nathke I.S., and Henderson B.R. Redefining the subcellular location and transport of APC: new insights using a panel of antibodies. EMBO Rep. 6 (2005) 184-190
5. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab. Brain Dis. 17 (2002) 221-227
6. Cadoret A., Ovejero C., Saadi-Kheddouci S., Souil E., Fabre M., Romagnolo B., Kahn A., and Perret C. Hepatomegaly in transgenic mice expressing an oncogenic form of β-catenin. Cancer Res. 61 (2001) 3245-3249
7. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., Kitajewski J., Kahn A., and Perret C. New targets of β-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21 (2002) 8293-8301
8. Chambrey R., Goossens D., Bourgeois S., Picard N., Bloch-Faure M., Leviel F., Geoffroy V., Cambillau M., Colin Y., Paillard M., et al. Genetic ablation of Rhbg in the mouse does not impair renal ammonium excretion. Am. J. Physiol. Renal Physiol. 289 (2005) F1281-F1290
9. Colnot S., Decaens T., Niwa-Kawakita M., Godard C., Hamard G., Kahn A., Giovannini M., and Perret C. Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 101 (2004) 17216-17221
10. Colnot S., Niwa-Kawakita M., Hamard G., Godard C., Le Plenier S., Houbron C., Romagnolo B., Berrebi D., Giovannini M., and Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest. 84 (2004) 1619-1630
11. de La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., Fabre M., Chelly J., Beldjord C., Kahn A., and Perret C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 95 (1998) 8847-8851
12. Gebhardt R., and Gaunitz F. Cell-cell interactions in the regulation of the expression of hepatic enzymes. Cell Biol. Toxicol. 13 (1997) 263-273
13. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003) 1-24
14. Haussinger D. Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Eur. J. Biochem. 133 (1983) 269-275
15. Haussinger D., Lamers W.H., and Moorman A.F. Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme 46 (1992) 72-93
16. Holm T.M., Jackson-Grusby L., Brambrink T., Yamada Y., Rideout III W.M., and Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8 (2005) 275-285
17. Ishizaki Y., Ikeda S., Fujimori M., Shimizu Y., Kurihara T., Itamoto T., Kikuchi A., Okajima M., and Asahara T. Immunohistochemical analysis and mutational analyses of β-catenin, Axin family and APC genes in hepatocellular carcinomas. Int. J. Oncol. 24 (2004) 1077-1083
18. Jungermann K., and Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu. Rev. Nutr. 16 (1996) 179-203
19. Jungermann K., and Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31 (2000) 255-260
20. Kielman M.F., Rindapaa M., Gaspar C., van Poppel N., Breukel C., van Leeuwen S., Taketo M.M., Roberts S., Smits R., and Fodde R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat. Genet. 32 (2002) 594-605
21. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
22. Kruithof-de Julio M., Labruyere W.T., Ruijter J.M., Vermeulen J.L., Stanulovic V., Stallen J.M., Baldysiak-Figiel A., Gebhardt R., Lamers W.H., and Hakvoort T.B. The RL-ET-14 cell line mediates expression of glutamine synthetase through the upstream enhancer/promoter region. J. Hepatol. 43 (2005) 126-131
23. Kuhnert F., Davis C.R., Wang H.T., Chu P., Lee M., Yuan J., Nusse R., and Kuo C.J. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl. Acad. Sci. USA 101 (2004) 266-271
24. Kuo F.C., Hwu W.L., Valle D., and Darnell Jr. J.E. Colocalization in pericentral hepatocytes in adult mice and similarity in developmental expression pattern of ornithine aminotransferase and glutamine synthetase mRNA. Proc. Natl. Acad. Sci. USA 88 (1991) 9468-9472
25. Legoix P., Bluteau O., Bayer J., Perret C., Balabaud C., Belghiti J., Franco D., Thomas G., Laurent-Puig P., and Zucman-Rossi J. β-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene 18 (1999) 4044-4046
26. Lindros K.O., Oinonen T., Issakainen J., Nagy P., and Thorgeirsson S.S. Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver. Cell Biol. Toxicol. 13 (1997) 257-262
27. Loeppen S., Schneider D., Gaunitz F., Gebhardt R., Kurek R., Buchmann A., and Schwarz M. Overexpression of glutamine synthetase is associated with β-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res. 62 (2002) 5685-5688
28. Lowry W.E., Blanpain C., Nowak J.A., Guasch G., Lewis L., and Fuchs E. Defining the impact of β-catenin/Tcf transactivation on epithelial stem cells. Genes Dev. 19 (2005) 1596-1611
29. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., and Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22 (2002) 1184-1193
30. Moorman A.F., de Boer P.A., Geerts W.J., van den Zande L., Lamers W.H., and Charles R. Complementary distribution of carbamoylphosphate synthetase (ammonia) and glutamine synthetase in rat liver acinus is regulated at a pretranslational level. J. Histochem. Cytochem. 36 (1988) 751-755
31. Murtaugh L.C., Law A.C., Dor Y., and Melton D.A. β-catenin is essential for pancreatic acinar but not islet development. Development 132 (2005) 4663-4674
32. Oinonen T., and Lindros K.O. Zonation of hepatic cytochrome P-450 expression and regulation. Biochem. J. 329 (1998) 17-35
33. Ovejero C., Cavard C., Perianin A., Hakvoort T., Vermeulen J., Godard C., Fabre M., Chafey P., Suzuki K., Romagnolo B., et al. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of β-catenin in the liver. Hepatology 40 (2004) 167-176
34. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Nathke I.S., et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18 (2004) 1385-1390
35. Saudubray J.M. Inborn errors of metabolism. Semin. Neonatol. 7 (2002) 1
36. Smith K.J., Johnson K.A., Bryan T.M., Hill D.E., Markowitz S., Willson J.K., Paraskeva C., Petersen G.M., Hamilton S.R., Vogelstein B., et al. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA 90 (1993) 2846-2850
37. Spicer J., and Ashworth A. LKB1 kinase: master and commander of metabolism and polarity. Curr. Biol. 14 (2004) R383-R385
38. Stahl S., Ittrich C., Marx-Stoelting P., Kohle C., Altug-Teber O., Riess O., Bonin M., Jobst J., Kaiser S., Buchmann A., and Schwarz M. Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 42 (2005) 353-361
39. Taniguchi K., Roberts L.R., Aderca I.N., Dong X., Qian C., Murphy L.M., Nagorney D.M., Burgart L.J., Roche P.C., Smith D.I., et al. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21 (2002) 4863-4871
40. Tannour-Louet M., Porteu A., Vaulont S., Kahn A., and Vasseur-Cognet M. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology 35 (2002) 1072-1081
41. Tordjmann T., Berthon B., Jacquemin E., Clair C., Stelly N., Guillon G., Claret M., and Combettes L. Receptor-oriented intercellular calcium waves evoked by vasopressin in rat hepatocytes. EMBO J. 17 (1998) 4695-4703
42. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
43. van Noort M., Meeldijk J., van der Zee R., Destree O., and Clevers H. Wnt signaling controls the phosphorylation status of β-catenin. J. Biol. Chem. 277 (2002) 17901-17905
44. Watford M., and Smith E.M. Distribution of hepatic glutaminase activity and mRNA in perivenous and periportal rat hepatocytes. Biochem. J. 267 (1990) 265-267
45. Weiner I.D., and Verlander J.W. Renal and hepatic expression of the ammonium transporter proteins, Rh B and Rh C glycoprotein. Acta Physiol. Scand. 179 (2003) 331-338
46. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H., and Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA 102 (2005) 13580-13585
47. Yu H., Yoo P.K., Aguirre C.C., Tsoa R.W., Kern R.M., Grody W.W., Cederbaum S.D., and Iyer R.K. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J. Histochem. Cytochem. 51 (2003) 1151-1160